New product: Revolade (eltrombopag olamine) oral suspension

As with film-coated tablets, oral suspension is indicated for treatment of patients’ ≥ 1 year with primary immune thrombocytopenia, adults with chronic hepatitis C virus and thrombocytopenia, and adults with acquired severe aplastic anaemia.

Source:

electronic Medicines compendium